Mediclinic surges as it jumps back to prepandemic revenue
Income rises more than 9%, hospital group encouraged by return of nonelective operations
15 October 2021 - 10:14
UPDATED 17 October 2021 - 20:55
Mediclinic’s share price surged more than 11% on Friday, its best day in 15 months, after SA’s most valuable hospital operator reported a bounce-back in revenue for its local unit amid a promising return of non-elective surgeries.
The group, valued at R46.2bn on the JSE, operates in Switzerland, the Middle East and SA. Like other hospital operators it was hit by the pandemic, which resulted in additional staff and equipment costs, while nonurgent medical procedures were put off...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.